1811510-56-1
中文名称
化合物PF6260933
英文名称
PF-6260933
CAS
1811510-56-1
分子式
C16H13ClN4
分子量
296.75
MOL 文件
1811510-56-1.mol
更新日期
2023/03/20 15:41:27
![1811510-56-1 结构式](/CAS/20200611/GIF/1811510-56-1.gif)
基本信息
中文别名
化合物PF6260933 英文别名
PF06260933PF-6260933
[3,3'-Bipyridine]-6,6'-diamine, 5-(4-chlorophenyl)-
PF 06260933
PF06260933
PF6260933
PF 6260933
PF-6260933
所属类别
生物化工:激动剂抑制剂物理化学性质
沸点483.8±40.0 °C(Predicted)
密度1.330±0.06 g/cm3(Predicted)
储存条件-20°C储存
溶解度DMF: 1 mg/ml; DMSO: 1 mg/ml; Ethanol: insol; PBS (pH 7.2): insol
酸度系数(pKa)5.04±0.13(Predicted)
形态固体
常见问题列表
生物活性
PF-6260933 (PF-06260933)是MAP4K4抑制剂,IC50为3.7 nM,具有良好的激酶组选择性。靶点
Target | Value |
MAP4K4
() | 3.7 nM |
体外研究
PF-06260933 treatment of human aortic endothelial cell (EC) robustly prevents TNF-α-mediated endothelial permeability in vitro , similar to MAP4K4 knockdown.
体内研究
In the mice model, PF-06260933 treatment does not alter plasma lipid content, although reductions in glucose levels are observed, which is consistent with whole-body-inducible Map4k4 knockout animals. PF-06260933 administration ameliorates further plaque development and/or promotes plaque regression in this animal model (46.0% versus 25.5%), and a reduction in plasma glucose as well as lipid content is also observed.